A Propensity Score Analysis Shows that Empirical Treatment with Linezolid Does Not Increase the Thirty-Day Mortality Rate in Patients with Gram-Negative Bacteremia
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.